Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

In VivoEfficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models

(2011) Noe Reyes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay

(2010) G. Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthesis and Spectrum of the Neoglycoside ACHN-490

(2010) J. B. Aggen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combating evolution with intelligent design: the neoglycoside ACHN-490

(2010) Eliana S Armstrong et al.   CURRENT OPINION IN MICROBIOLOGY

Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City

(2010) D. Landman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

(2010) D. Landman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Management of Aminoglycosides in the Intensive Care Unit

(2010) Elizabeth A. Radigan et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Do we still need the aminoglycosides?

(2008) Emanuele Durante-Mangoni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS